Evoke Pharma (EVOK) P/E (2013 - 2025)
Evoke Pharma (EVOK) P/E from Sep 25, 2013 to Dec 17, 2025. The TTM Evoke Pharma (EVOK) P/E is -3.23. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Evoke Pharma (EVOK)
| Year | P/E | Change |
|---|---|---|
| 2025 | -3.23 | +353.30% |
| 2024 | -0.71 | -9.80% |
| 2023 | -0.79 | -21.11% |
| 2022 | -1.00 | -52.11% |
| 2021 | -2.09 | -58.83% |
| 2020 | -5.08 | +1.43% |
| 2019 | -5.01 | -25.78% |
| 2018 | -6.75 | -45.57% |
| 2017 | -12.40 | +11.88% |
| 2016 | -11.08 | -38.79% |
| 2015 | -18.11 | -44.43% |
| 2014 | -32.59 | -65.80% |
| 2013 | -95.28 | N/A |
Comparison Evoke Pharma (EVOK) P/E with competitors
Evoke Pharma (EVOK) P/E is -3.23.